At a glance
ClinicalIndex Comparison RecordN/ACompleted· 286 enrolled
Drug / intervention
memsorbdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A New and Innovative Method for CO2 Removal in Anesthetic Circuits: Replacing Chemical Granulate
In Brief
A clinical study evaluating memsorb for Anesthesia. Completed, enrolled 286 participants across 2 sites.
Detailed Summary
The drawbacks of chemical CO2 absorbers include the production of compounds harmful to patients that also lead into increased cost and environmental impact, as well as the daily disposal of compound special waste. Sustainable management of general anesthesia is a growing concern. Continually diluting anesthetic circuits, and the disposal of chemical granulate are serious environmental problems.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnesthesia
CountriesCanada
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJan 2017
Enrollment StartMar 2017
Primary CompletionMay 2022
Study CompletionJul 2024
TodayJul 2026
First PostedJan 9, 2017
Enrollment StartMar 20, 2017
Primary CompletionMay 10, 2022
Study CompletionJul 24, 2024
TodayJul 2, 2026
Enrollment to primary: 5.1 yearsPosted 9.5 years ago
Interventions
memsorbdevice
memsorb is a CO2 filter replacing current chemical CO2 absorbers